Concepedia

Pamela Cohen

PC

Statistics

Publications

23

Citations

3.3K

H-Index

22

Active since

1984

Affiliations

Dana-Farber Cancer Institute(Current)

North Shore University Hospital

Massachusetts General Hospital

The University of Texas MD Anderson Cancer Center

Novartis (United States)

Pamela Cohen is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pharmacology.

Publications per year

1984–2020

23

Publications

23

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412

Richard M. Stone, Daniel J. DeAngelo, Virginia M. Klimek et al. · Blood · 2004 · 660 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Spermine Inhibits Proinflammatory Cytokine Synthesis in Human Mononuclear Cells: A Counterregulatory Mechanism that Restrains the Immune Response

Minghuang Zhang, Theresa Caragine, Haichao Wang et al. · The Journal of Experimental Medicine · 1997 · 318 citations · Full text

Medicine, Immunology, Pharmacology +15

Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand <sup>18</sup>F-AH111585 in Breast Cancer Patients

Laura Kenny, R. Charles Coombes, Inger Oulie et al. · Journal of Nuclear Medicine · 2008 · 277 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain

Florian H. Heidel, Fian K. Solem, Frank Breitenbuecher et al. · Blood · 2005 · 268 citations

Medicine, Oncology, Pharmacology +17

Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines.

Stephen D. Smith, M Shatsky, Pamela Cohen et al. · PubMed · 1984 · 242 citations

Medicine, Immunology, Oncology +13

1–5 of 23